Navigation Links
Generex Provides Additional Details for October 21st Live Video Webcast
Date:10/20/2010

ef="mailto:bradley.smith@muncmedia.com">bradley.smith@muncmedia.com Webcast:

http://investor.generex.com/events.cfmSenior executives are available for media and analyst interviews prior and post the live event. Please contact Bradley Smith to schedule 917.680.6011 or bradley.smith@muncmedia.com

About Generex Biotechnology Corporation Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).  The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  The Company's buccal insulin spray product, Generex Oral-lyn™, which has been approved in India, Lebanon, Algeria, and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Safe Harbor Statement This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements can
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
2. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
3. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
4. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
5. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
6. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
7. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
8. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
9. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
10. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
11. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... June 1, 2015 Shire plc ... will be participating in the Jefferies 2015 Global Healthcare ... on Tuesday, June 2, 2015. Jeff Poulton , ... answer session at 10:00 a.m. ET (3:00 p.m. BST). ... on the Presentations and Webcasts section of Shire,s Investor ...
(Date:6/1/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/tdw3ss/2015_strategies ) has ... in the UK Flow Cytometry Market" report ... a comprehensive analysis of the UK flow cytometry ... the French flow cytometry practice, as well as ... with significant market impact during the next five ...
(Date:6/1/2015)... 1, 2015 Hutchison China ... AstraZeneca AB (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") ... Phase Ib clinical trial of HMP,s c-Met inhibitor ... in non-small cell lung cancer ("NSCLC"). ... growth factor receptor (EGFR). Preliminary data on the ...
(Date:5/31/2015)... 31, 2015 The most heavily attended ... Clinical Oncology (ASCO) Annual Meeting – “The Plenary Session ... prominently featured presentations by immunotherapy experts and members of ... Patrick Allison, PhD, chairman of the Department of Immunology ... and SITC committee member, received the Science of Oncology ...
Breaking Biology Technology:Strategies in the UK Flow Cytometry Market 2015 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3SITC Reports on Immunotherapy Insights and Data Featured at ASCO Plenary Session 2
... - The Wisconsin Economic Summit served its purpose by ... summits that took place between 2000 and 2003 were ... are shaping the state's growth. But once those general ... do something about them, the Wisconsin Economic Summit needed ...
... A company whose fuel technology was developed at the ... of Wisconsin-Madison has been acquired by Xethanol Corp. ... Inc. (XTI), was a wholly owned subsidiary of ... Fla. , ,Xethanol Corp. is a biotechnology-driven ethanol production ...
... surge in interest in a conference on protecting the U.S. ... organizers to postpone the event until spring from its original ... was originally slated for Nov. 1-3 in downtown Milwaukee, with ... region, including Canada, according to David Duecker, who, with the ...
Cached Biology Technology:Forum builds on the work of the Wisconsin Economic Summit 2Forum builds on the work of the Wisconsin Economic Summit 3
(Date:4/27/2015)... more than four decades, AUVSI,s Unmanned Systems ... event for the unmanned land, sea, and air industries. ... local, national, or trade news organization interested in gathering ... applications of unmanned technologies. The conference will explore the ... and how it will soon impact the lives of ...
(Date:4/21/2015)... 2015 High crime rate, ... boosting access control systems market in Saudi ... recently published report by TechSci Research " Saudi Arabia Access ... control systems market in Saudi Arabia ... access control systems market in the Kingdom is growing ...
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... Spaniards to bask in regions like the Costa del Sol ... protect their paler skin or risk skin cancer is due ... MC1R gene locus. The MC1R gene, expressed in skin and ... to African populations. Now, a team of researchers led ...
... is participating in the nationwide ABSORB III clinical trial ... fully dissolvable and temporary drug eluting stent to open ... the efficiency and safety of Absorb Bioresorbable Vascular Scaffolds ... it to the current standard of care drug ...
... Vaginal delivery presents the possibility of injury for mothers ... condition affecting from four to 35 percent of women ... treatments, such as physiotherapy and surgery, are not very ... carried out a study in which female laboratory rats ...
Cached Biology News:Evolutionary medicine of skin cancer risk among Europeans 2Fully dissolvable, temporary stent for opening heart artery blockages 2Mesenchymal stem cell transplantation may heal a mother's childbirth injury 2
... High Sensitivity Laboratory Osmometer for both 0.2 and 2.0 mL samples for freezing ... record keeping. Bar code reading capability with optional scanner. RS-232 port. ... ... ...
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
X-Gal...
Recombinant Rat CINC-2 alpha, CF...
Biology Products: